Home » Newsletters » BioWorld Asia

BioWorld Asia

Feb. 14, 2001

View Archived Issues

New Target For Thrombotic Drugs Could Increase Safety

Genset Cuts Back Genomics Focus, Moves On To Discovery

British Biotech's Marimistat Fails In Promising Indication

Oxford Glyco Plans Gaucher NDA On Cerezyme Comparison Study

Despite Resistance In France, Chirac Sees Place For GM Crops

Acambis Achieves Early Results That Validate Flavivirus Vaccine

Curacyte Gets Into Full Swing With US$6.5M Seed Financing

KS Biomedix Moves Lead Drug Into Phase IIb, Eyes Pivotal Trial

Antisoma Planning Financing To Stay Ahead, Keep Flexibility

French Advancing Legislation To Allow Therapeutic Cloning

Hybrigenics, Servier Collaborate On Discovery Of Cancer Drugs

Medica Strengthens Position With Kinase-Targeting Filings

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 27, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Probing bidirectional cancer-autoimmune link can yield new targets
BioWorld Science
Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.